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Endothelial Cell Seeding of De-endothelialised Human Arteries: 
Improvement by Adhesion Molecule Induction and Flow-Seeding 
Technology* 
K.P. Wal luscheck t, G. Steinhoff and A. Haverich 
Department of Cardiovascular Surgery, University of Kiel, Germany 
Objectives: To assess re-endothelialisation of denuded human arteries by two different seeding techniques using adhesion 
molecule induction and a dynamic flow-seeding. 
Design: Prospective, open study. 
Setting: University Department of Cardiovascular Surgery. 
Materials and methods: In the first group (I) segments of human common carotid arteries (n = 4) were balloon-denuded, 
short-time seeded with cultured adult human venous endothelial cells (EC) and exposed to a mock circulation. In the second 
group (II)(n = 4), EC were incubated with a synthetic RGD peptide (arginine-glycine-aspartate) prior to seeding with the 
aim of upregulating the cellular adhesion molecules and increasing EC attachment. In the third group (III)(n = 4), EC were 
seeded not using the common technique of instillating cells and sequentially rotating the graft but by a dynamic flow 
application. The percentage of EC-covered luminal surface was assessed by image analysis of scanning electron 
micrographs. 
Results: EC attachment was significantly increased in groups II (73%) and III (94%) compared with group I (34%). In 
group III, a preconfluent monolayer could be established immediately after seeding. One hour of artificial perfusion resulted 
in no significant EC loss in any of the study groups. 
Conclusions: RGD-peptide preincubation improves EC seeding of biological surfaces. Because of accelerated seeding times 
it may have good potential for clinical applications. The flow-seeding technology may be indispensable if EC seeding of the 
vascular surface of complete organ systems i  required. 
Key Words: Endothelial ceil; Seeding; Human arteries; Adhesion molecules; Integrins; RGD-peptides. 
Introduction 
Surgical techniques, uch as arterial thromboendarter- 
ectomy (TEA) or endovascular catheterisation tech- 
niques, such as the percutaneous transluminal ngio- 
plasty (PTA), often result in endothelial damage 
ranging from local disruption up to complete denuda- 
12 tion.' Because of the decrease in anticoagulant 
properties 3-6 endothelial injury correlates with vas- 
cular re-occlusion especially in small-diameter a ter- 
ies. 7'8 Physiological EC regeneration of de-endotheli- 
alised vessels has been shown to be a time consuming 
process in animal models, 7"9A° and is dependent on 
the severity of injury. 11 In clinical situations of induced 
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intimal damage, fast re-establishment of an EC mono- 
layer by application of EC seeding techniques appears 
to be a promising method for increasing patency rates. 
A human clinical study with EC seeded artificial 
vascular prostheses in femoropopliteal bypass graft- 
ing has demonstrated a superior 3year patency of 85% 
for endothelialised grafts compared with 55% for 
unseeded grafts. 12 Studies on the EC seeding of native 
arteries have only been performed in several animal 
models. 19 
The aims of our study were to demonstrate the 
feasibility of human EC seeding in denuded human 
arteries and to improve seeding by application of two 
new technologies. Prior to seeding, we preincubated 
EC with a synthetic RGD-peptide (arginine-glycine- 
aspartate), known to be recognised by cellular adhe- 
sion molecules, 13'14 to increase EC attachment on the 
vascular surface and to reduce the seeding time. 
Furthermore, we transformed the commonly applied 
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seeding procedure, consisting of the instillation of EC 
and subsequent graft rotation, 15'~6 in a setup employ- 
ing dynamic flow-seeding. 
Material and Methods 
Cell harvest 
Adult human venous EC were harvested from excess 
saphenous vein material during open heart proce- 
dures and grown in cell culture using techniques 
previously described in detail) 7Cells from the second 
to third passage were used for seeding after identifica- 
tion as endothelium by staining for factor VIII-related 
antigen with the peroxidase-antiperoxidase reaction 
and by microscopic assessment. 
Arterial de-endothelialisation 
The aortic arch, including short segments of the supra- 
aortic branches, is regularly explanted for orthotopic 
heart transplantation. I  accordance with the Ethical 
Committee of the University of Kiel, usually discarded 
segments of human common carotid arteries obtained 
from heart ransplant donors were used within twelve 
hours after explanation. The segments were stored at 
4°C in medium M-199 (Sigma Chemical Co., St.Louis, 
MO, U.S.A.) containing 100 units/ml penicilline 
(Sigma Chemical Co). and 100 /~g/ml streptomycin 
(Sigma Chemical Co.). Arterial de-endothelialisation 
was performed by balloon-catheter removal. A 6 
french balloon embolectomy catheter (Baxter, Unters- 
chlei~heim, Germany) was introduced, inflated to a 
pressure of 25 psi and passed 10 times through the 
vessel segment. To confirm complete denudation, 
specimens were prepared as previously described 17
and assessed by scanning electron microscopy (SEM) 
(Philips XL 20, Kassel, Germany). For this purpose, 
five specimens along the longitudinal extension and 
four specimens along the arterial circumference of
each graft (n = 12) were investigated. 
EC seeding 
EC were isolated from tissue culture by trypsinisation, 
counted in a haemocytometer (Fuchs-Rosenthal, Supe- 
rior, Germany) and adjusted to a seeding density of 1.2 
5 2 × 10 EC/cm in complete culture medium (M-199 
with L-glutamine, 10% pooled human serum, 100 
units/ml penicilline, 100 ]zg/ml streptomycin, 500 
units/ml preservative-free h parin (Heparin Novo, 
Nordisk, Mainz, Germany). A specially designed 
tubing system (Fresenius, Bad Homburg, Germany) 
was fixed by a ligature at both ends of an arterial 
segment of approximately 4 cm length and a mean 
internal diameter of 0.7 cm. For static EC seeding of 
study groups I and II, the EC suspension was instilled, 
the connecting tubes occluded and the vessel incu- 
bated for 30 min in a humidified incubator (Forma 
Scientific, Marietta, GA, U.S.A.) in a 5% carbon 
dioxide/95% air atmosphere at a constant tem- 
perature of 37°C. The system was rotated by 180 
degrees for the second half of the seeding time. 
For dynamic EC seeding of study gToup III, the 
denuded arterial segment was placed in a specially 
designed glass tube (Hampe, Kiel, Germany) sur- 
rounded by culture medium (37°C). Both ligated tubes 
were connected to a tubing system (IVAC, San Diego, 
CA, U.S.A.) by three-way stopcocks thereby forming a 
closed circuit. The circuit was completely filled with 
EC suspension by use of a standard syringe. A mini- 
roller pump was used to establish a calibrated flow of 
7 ml / min during a seeding time of 30 min. A further 
roller pump (Medax, Kiel, Germany) and extrac- 
orporal perfusion circuit (Jostra, Hirrlingen, Ger- 
many), filled with medium M-199 and submerged in a 
water bath, were applied to continuously provide a 
temperature of 37°C inside the glass tube containing 
the artery. After ephemeral removal of the tubing and 
brief rinsing in culture medium a defined subsegment 
of the vessel was dissected for SEM. 
Mock circulation 
For subsequent evaluation of EC growth on the native 
surface under the influence of shear stress the arteries 
were immediately placed into an artificial flow circuit, 
as previously described in detail) 7In brief, the system 
consisted of a roller pump, a cardiotomy reservoir, a
silicone extracorporal perfusion circuit and a special 
glass tube enclosing the arterial segment. The system 
was primed with culture medium at 37°C and a 
pulsatile flow of 100 ml / ra in  was applied for one 
hour. 
Evaluation of re-endothelialisation 
A segment of the arterial circumference p rpendicular 
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to the main deposition force during the first 15 min of 
EC incubation had been marked prior to seeding. 
Therefore, investigated samples had been exposed to 
identical seeding density. After perfusion, a further 
subsegment was dissected and assessed by SEM. The 
percentage of EC-covered area was determined by 
utilisation of SEM-prints of identical magnification 
with an image analysing device (IBAS-1, Kontron, 
Eichach, Germany). From each sample the mean count 
of five randomly chosen measurements was calcu- 
lated. In each study group mean values of EC-covered 
area after seeding and after perfusion were calculated 
from these data. Data were then analysed for statistical 
significance using Student's t-test with p values less 
than 0.05 considered significant. 
Study groups 
Group I. Arterial segments (n = 4) were de-endotheli- 
alised, seeded with EC in a static technique with one 
single graft rotation, and exposed to shear stress in an 
artificial perfusion circuit (Fig. 1). 
Group IL In this group (n = 4), EC harvesting and 
culture techniques as well as the methods of de- 
endothelialisation, seeding and artificial perfusion 
were identical to group I, but prior to seeding EC were 
incubated with a synthetic RGD-peptide with the aim 
of upregulate cellular adhesion molecules and increas- 
ing EC attachment (Fig. 1). After adjustment of~ the EC 
sus~pension to the seeding density of 1.2 × 105 EC/ 
cm and subsequent centrifugation (5min, 300 g) the 
resulting cell pellet was incubated with 350/zg/ml of 
a synthetic, the RGD-sequence containing, peptide 
(Gly-D-Arg-GIy-Asp-Ser-Pro-Lys)(Gibco, Life Technol- 
ogies Inc., Gaithersburg, MD, U.S.A.) in culture 
medium at 37°C for 60 min. The suspension was 
washed with medium M-199, centrifugated and EC 
resuspended in the previously calculated volume of 
culture medium. The preincubated EC were now 
instilled into the arterial segment and the investiga- 
tion continued. 
Group III. Conduction of the experiments in this group 
(n -- 4) differs from group I only in management of EC 
seeding (Fig. 1). While in group I EC were seeded 
using the common technique of instilling cells and 
sequentially rotating the graft, in group III dynamic 
EC flow was applied during the entire seeding time. 
Study group I NNN~IStudy  group II ) 
De-endothelialisation 
1 
Study group III 
EC seeding 
-static- 
EC pre-incubation with a RGD-peptide 
1 
EC seeding [ 
-static- 
Artificial perfusion 
EC seeding 
-dynamic- 
Fig. 1. Schematic drawing of EC seeding process ingroups I, II and III. 
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Fig. 2. Scanning electron micrograph of a de-endothelialised human 
common carotid artery. After balloon-catheter de-endothelialisation 
the endothelial monolayer has been removed completely, showing 
the extracellular matrix. Original magnification × 209. The scale 
bar represents 20/xm. 
Results 
A comparison of EC adhesion on de-endothelialised 
human arteries, measured in percentage of EC-cov- 
ered area, was performed after seeding and after 
subsequent artificial perfusion. Figs. 2-5 show scan- 
ning electron micrographs of the luminal surface 
taken from specimens of the examined arterial seg- 
ments of the study groups I to III. 
Group I. In balloon-de-endothelialized human arterial 
segments SEM revealed 34% (29-41%) of the luminal 
surface to be covered with EC immediately after 
seeding. Application of shear stress by means of a 
Fig. 4. Scanning electron micrograph of a de-endothelialised human 
common carotid artery after EC pre-incubation with an RGD- 
peptide and subsequent seeding (group II). After 30 rain of EC 
seeding (1.2 × 10 EC/cm a) the extracellular matrix is nearly 
covered with spreading EC and some rounded EC. Original 
magnification × 209. The scale bar represents 20/xm. 
mock circulation resulted in an insignificant increase 
of EC-coverage to 38% (23-45%)(Fig. 6). 
Group II. Preincubation of EC with the RGD-peptide 
lead to an EC-coverage after seeding of 73% (51-91%). 
After perfusion, 98% (93-100%) of the surface was 
covered with endothelium (Fig. 6). Compared with 
group I, there was a significant increase in EC 
adhesion after seeding (p= < 0.05) as well as after 
perfusion (p = < 0.0001). 
Group IlL Changing the seeding procedure from static 
to dynamic seeding resulted in a preconfluent EC- 
coverage of 94% (89-100%) after 30 min of seeding. 
After perfusion, a completely confluent endothelial 
Fig. 3. Scanning electron micrograph of a de-endothelialised human 
common carotid artery after EC seeding (group I). After 30 min of 
o l  2 EC seeding (1.2 × 10 EC/cm ) several rounded or spreaded EC are 
localized on the underlying extracellular matrix. Original magnifi- 
cation × 209. The scale bar represents 20/xm. 
Fig. 5. Scanning electron micrograph of a de-endothelialised human 
common carotid artery after EC flow-seeding (group III). After 30 
min of EC seeding by application of a dynamic EC flow (1.2 × 105 
EC/cm z) the extracellular matrix is covered with flattened EC. 
Original magnification × 209. The scale bar represents 20/xm. 
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monolayer was detectable in three of four vessels 
resulting in 99% (95-100%) EC-coverage (Fig. 6). There 
was a significant increase in EC adhesion after seeding 
(p = < 0.0001) and after perfusion (p = 0.0014) in group 
III compared with group I. No significant differences 
were noted in comparison with group II (p = 0.15 / p = 
0.57). 
Discussion 
The first step towards EC seeding of artificial vascular 
prostheses was made in 1975.18 Recently, the superior- 
ity of lining small-diameter a tificial grafts in clinical 
experiments was demonstrated by the impressive 
results of Zilla et al. 12 However, the numerous possi- 
bilities of seeding native vascular surfaces in humans 
have not been examined in a systematic fashion. Only 
a few groups have investigated the feasibility of EC 
seeding of human tissue, like heart valves 19 or arterial 
sites after thromboendarterectomy. 2° Nevertheless, 
new techniques for a more effective EC seeding of de- 
endothelialized human arteries may open new possi- 
bilities for repairing endothelial damage. 
EC injury is known to be caused by mechanical 
disruption and by chemical damage, as well as by 
ischaemia, hyperoxic exposure ~9 or air drying. 7 In 
several animal models mechanical injury has been 
shown to be induced by balloon-catheterisation 1'2'11'21 
and the high rate of arterial re-occlusion after clinical 
percutaneous transluminal angioplasty (PTA) is often 
attributed to de-endothelialisation. 7's Likewise surgi- 
cal techniques often result in complete removal  of the 
endothelial monolayer. Early restitution of an intact 
endothel ium after unintentional de-endothelialisation 
may be an indication for EC seeding vascular surfaces. 
However, quick seeding technologies, providing a 
rapid confluent monolayer while preventing pro- 
longed organ ischaemia, are an important prerequisite 
for extending the clinical applications. 
In our study, we compare three different seeding 
techniques after bal loon-denudation f human arter- 
ies. The technology applied in group I would repre- 
sent the "conventional" method of re-endothelialising 
arterial sites, as previously used in several animal 
i00 
80 
60 
~9 
40 
N 20 
(a) 
After seeding 
100 
41 
1 
29 
34 
91 
51 
73 
89 
Group I Group II Group III 
100 
80 
6o 
40 
20 
(b) 
After perfusion 
100 100 
98 
9'3 95 
45 
23 
Group I Group II Group III 
99- 
Fig. 6. Comparison of EC adhesion on human common carotid arteries seeded in three different techniques. Arteries of group I (n = 4) were 
seeded in a conventional technique by instillation of EC suspension and graft rotation. I  group II (n = 4) the EC were pre-incubated with 
an RGD-peptide to improve attachment by adhesion molecule induction. Subsequently, a seeding process as performed in group I was used. 
The arteries of group III (n = 4) were seeded by application of a dynamic flow of the EC suspension. The EC-covered area (%) (a)after 30 
• 5 2 mm of seeding (1.2 × 10 EC/cm ) and (b) after 60 min of perfusion in a flow circuit (100ml/min) is demonstrated (median and range 
values). 
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models. 22-24 It is characterised by the instillation of EC 
suspension into a defined arterial segment and sub- 
sequent static incubation for a defined seeding time. In 
our investigation, we added an artificial perfusion for 
application of shear stress, giving evidence of the 
strength of EC attachment to the extracellular matrix. 
SEM, performed immediately after EC seeding, 
revealed 34% (29-41%) of the arterial surface lined 
with endothelium. After in vitro perfusion there was 
an EC-coverage of 38% (23-45%). In contrast to 
previous tudies of our own 17 and other groups 25'26 on 
EC seeding artificial vascular prostheses there was no 
significant cell loss after high-flow perfusion applied 
to the freshly attached EC. We attribute this fact to the 
superior extracellular matrix provided by the bio- 
logical surface in comparison with vascular prostheses 
only precoated with selected matrix proteins. Saw- 
chuk et al. 27 described 35% EC-coverage on de- 
endothelialised carotid arteries after one hour of 
seeding as well as after in vivo perfusion in a dog- 
model a result confirming our data on human 
arteries. 
In group II we added the application of a RGD- 
peptide to the method used in group I. The RGD- 
tripeptide sequence was identified as the minimal 
amino acid attachment sequence of integrin cell matrix 
adhesion receptors to matrix proteins such as fibro- 
nectin, laminin or tenascin. 28-35 In previous investiga- 
tions, RGD-peptides have been ~ used to increase 
endothelial cell attachment on artificial surfaces as 
polytetrafluoroethylene (PTFE) or polyurethane 
(PU). 17"36~° In these studies, the RGD-peptide was 
bound to PTFE and used to directly mediate cellular 
attachment between the EC and the prosthetic mate- 
rial replacing graft precoating with matrix proteins. 
We then preincubated the EC used for seeding of 
human arteries with an RGD-peptide prior to the 
seeding process. The aim was not a direct linkage of 
cell bound RGD-peptides to the arterial extracellular 
matrix, but to induce improved EC attachment by 
potential improvement of cellular adhesion 
mechanisms. 
Recent in vitro investigations revealed a partially 
inhibited EC attachment to selected matrix proteins 
after incubation with the RGD-sequence containing 
peptides. 41 But it was also shown that both RGD and 
non-RGD sites on matrix proteins mediate receptor 
binding. 41 In our experiments we achieved an 
improved EC attachment after preincubation of EC 
with a RGD-peptide. After seeding, 73% (51-91%) of 
the arterial luminal surface was covered with EC. 
After perfusion there even was an EC-coverage of 98% 
(93-100%), revealing a significant increase in EC 
attachment compared with the RGD-untreated sur- 
faces. In contrast o the previously mentioned inves- 
tigations, we have not only presented a single matrix 
protein, precoated on an artificial material, to the EC, 
but the complete physiological extracellular matrix of 
a fresh human artery exposing additional non-RGD 
integrin ligands. In our opinion, this is the main 
explanation for our paradoxical result that a potential 
receptor ligand blockade increases adhesive 
properties. 
The technique described may be clinically applica- 
ble for the endothelial cell seeding of denuded native 
surfaces. While endothelial cell seeding is feasable, a
great problem is the quick restitution of a durable and 
confluent endothelial monolayer, making clinical 
application practicable. Improvement of cellular 
attachment by adhesion molecule induction as 
described in study group II may be a conceivable 
technique to reach this aim. Previous studies, inves- 
tigating EC seeding of de-endothelialised native sur- 
faces, always used a so called "static" seeding tech- 
nique. An arterial segment was filled with EC 
suspension and the seeded cells followed the main 
deposition force during a defined time period remain- 
ing the graft unaffected. 19"23'24'27'42 Other groups 43 
used a technique of sequentially rotating the graft for 
some degrees as described by Zilla et al. ~2 in their 
clinical application of EC seeding artificial vascular 
prostheses. In 1995 Quigley et al. 44 described the 
application of a dynamic EC flow in their animal 
model with the aim of modulating alloreactivity in 
transplant recipients by phenotypic manipulation of 
donor endothelium. In their study the coronary ostia 
of a rat heart were randomly perfused with an EC 
suspension without foregoing de-endothelialisation. 
In study group III of our investigation, we could 
demonstrate for the first time the fast re-establishment 
of a complete EC monolayer after denudation of 
human arterial segments by application of a dynamic 
EC flow-seeding. Examination of the seeded grafts 
resulted in a nearly confluent EC-coverage of 94% 
(89-100%). After subsequent perfusion 99% (95-100%) 
of the luminal surface were covered with EC. We 
could show that continuously moving EC are able to 
attach themselves and restore the endothelium. This 
capability is important in trials for complete organ 
seeding where distant vascular sites have to be 
reached. EC seeding of native vascular surfaces of 
complex structure, as for example biologic or artificial 
heart valves, may take advantage of this technique as 
well. It has to be mentioned that the total amount of 
EC used in study group III was higher than in groups 
I and II because the perfusion circuit had to be primed. 
Nevertheless, due to the confluent seeding density in 
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study groups I and II there should be only a slight 
difference between the groups. 
In summar)5 endothelial damage following surgical 
interventions or percutaneous transluminal angio- 
plasty are conceivable clinical applications for EC 
seeding. We believe the induction of adhesion mole- 
cules by RGD-peptides and the flow-seeding technol- 
og34 alone or combined, to be promising techniques 
for reaching this aim. 
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